Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vincristine for treatment of transmissible venereal tumor in the dog--.

× No keyword cloud information.

8 in total

Review 1. Review of canine transmissible venereal sarcoma.

Authors: U Das; A K Das
Journal: Vet Res Commun Date: 2000-12 Impact factor: 2.459

2. Clinico-pathological studies on the effect of different anti-neoplastic chemotherapy regimens on transmissible venereal tumours in dogs.

Authors: J Singh; J S Rana; N Sood; G R Pangawkar; P P Gupta
Journal: Vet Res Commun Date: 1996 Impact factor: 2.459

3. A review of cancer chemotherapy for pet animals.

Authors: A M Norris; S J Withrow
Journal: Can Vet J Date: 1984-04 Impact factor: 1.008

4. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.

Authors: Abel Sánchez-Servín; Simón Martínez; Emilio Córdova-Alarcon; Raúl Fajardo
Journal: J Vet Sci Date: 2009-12 Impact factor: 1.672

5. Presence of the canine transmissible venereal tumor in the nasal cavity of dogs in the area of dakar (senegal).

Authors: R Parent; E Teuscher; M Morin; A Buyschaert
Journal: Can Vet J Date: 1983-09 Impact factor: 1.008

6. The changing global distribution and prevalence of canine transmissible venereal tumour.

Authors: Andrea Strakova; Elizabeth P Murchison
Journal: BMC Vet Res Date: 2014-09-03 Impact factor: 2.741

7. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.

Authors: Halit Kanca; Gizem Tez; Kazim Bal; Dogukan Ozen; Eray Alcigir; Sevil Atalay Vural
Journal: Vet Med Sci Date: 2018-08-17

8. Vincristine chemotherapy trials and pharmacokinetics in tasmanian devils with tasmanian devil facial tumor disease.

Authors: David N Phalen; Angela Frimberger; Stephen Pyecroft; Sarah Peck; Colette Harmsen; Suzanneth Lola; Beatriz de Mello Mattos; Kong M Li; Andrew J McLachlan; Antony Moore
Journal: PLoS One Date: 2013-06-06 Impact factor: 3.240

8 in total